Logo image of CRXT

CLARUS THERAPEUTICS HOLDINGS (CRXT) Stock Analyst Ratings

NASDAQ:CRXT - Nasdaq - US18271L1070 - Common Stock - Currency: USD

0.099  -0.06 (-36.94%)

After market: 0.101 +0 (+2.02%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to CRXT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.06. This target is 2990.91% above the current price.
CRXT was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CRXT.
In the previous month the buy percentage consensus was at a similar level.
CRXT was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

CRXT Historical Analyst RatingsCRXT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.103.033.063.063.15 - 2,960.61% 2,990.91% 2,990.91% 3,081.82%

Related screens

CRXT Current Analyst RatingCRXT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2022-08-23 Needham Downgrade Buy -> Hold
2022-08-22 Maxim Group Downgrade Buy -> Hold
2022-05-17 Needham Maintains Buy
2022-05-17 Truist Securities Maintains Buy
2021-10-13 Truist Securities Initiate Buy
2021-10-06 Needham Initiate Buy
2021-09-29 Maxim Group Initiate Buy
2021-09-20 Cantor Fitzgerald Initiate Overweight
2021-09-20 Oppenheimer Initiate Outperform